Research use only — all materials are supplied as laboratory reagents for in-vitro research. Not for human or veterinary consumption, medical, diagnostic or household use.
Free shipping over €300Ships within 24–48hHPLC-verified ≥99% purity
All articles
Research methods

Incretin Receptor Assays: Studying GLP-1R, GIPR and GCGR In Vitro

Dual and triple agonist reference peptides demand careful assay design. An overview of in-vitro incretin receptor pharmacology.

7 min read
In-vitro incretin receptor assay plates for tirzepatide and retatrutide research

The GLP-1, GIP and glucagon receptors are class B GPCRs that signal mainly through Gs and cAMP. Multi-receptor reference peptides have made comparative in-vitro pharmacology an active research field.

Core assay formats

  • cAMP accumulation (HTRF, luminescence or ELISA) in recombinant cell lines
  • Competition binding to determine receptor affinity
  • β-arrestin recruitment for signalling bias
  • Receptor internalisation imaging

Comparing multi-receptor peptides

Tirzepatide is studied as a dual GIPR/GLP-1R reference agonist, while Retatrutide is studied at GIPR, GLP-1R and GCGR. Running each receptor in parallel with a native-ligand control allows relative potency to be calculated reliably.

Practical tips

  1. Use low-binding plastics — lipidated peptides adsorb to surfaces.
  2. Include a carrier protein such as BSA in assay buffer where appropriate.
  3. Normalise to the native ligand's maximal response.
  4. Record lot numbers for every curve.

Related reagents: Tirzepatide and Retatrutide reference peptides. Each batch ships with documented HPLC purity and a Certificate of Analysis on request.

Share this article

Keep reading

More from the research notebook